Warrant
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: GBExchange: Nasdaq
DilutionScan read 64 of OKYO Pharma Ltd's SEC filings and found 1 warrant series, 3 convertibles, 2 ATM programs, 1 shelf registration and 1 completed offering on file for OKYO. The latest dilution event on file is an offering on Feb 17, 2026. Analysis updated Oct 18, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 259 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Feb 17, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Total capacity
Sold to date
Total capacity
Sold to date
Issued 2026
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z